Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-10-09

Clinical Trial Update: The Effects of ProFoveate on Reducing Self-Stimulating Behaviors [NA]

View source ↗

Summary

Clinical trial terminated; study on ProFoveate aimed to reduce self-stimulating behaviors in autism spectrum disorders with normal hearing/intelligence, results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ProFoveate

Snippet

Sponsor: University of Arkansas | Conditions: Autism Spectrum Disorders, Normal Hearing | NA | Status: TERMINATED | Results posted: 2020-10-09